Literature DB >> 31552532

Mutational landscape and intra-host diversity of human papillomavirus type 16 long control region and E6 variants in cervical samples.

Noé Escobar-Escamilla1,2, Blanca Estela González-Martínez3, Adnan Araiza-Rodríguez3, David Esaú Fragoso-Fonseca3, Abraham Pedroza-Torres4, Magaly Guadalupe Landa-Flores3, Fabiola Garcés-Ayala3, Edgar Mendieta-Condado3, José Alberto Díaz-Quiñonez3,5, Graciela Castro-Escarpulli6, José Ernesto Ramírez-González7.   

Abstract

Human papillomavirus genotype 16 (HPV16) is the most frequent high-risk HPV (HR-HPV) identified in cervical precursor lesions and cervical cancer (CC) worldwide. The oncogenic potential of HPV16 is partly dependent on the lineage involved in the infection and the presence of clinically relevant mutations. In this report, we present the distribution of HR-HPV and the mutational profile and intra-host variability of HPV16 lineages, based on analysis of the long control region (LCR) and the E6 gene in samples with normal cytology (n = 39), squamous intraepithelial lesions (n = 25), and CC (n = 39). HR-HPV genotyping was performed using multiplex real-time PCR. HPV16 lineage assignments and mutation frequencies were determined by conventional PCR and Sanger DNA sequencing, and intra-patient viral populations were analyzed using next-generation sequencing (NGS). The most frequent HR-HPV type was HPV16, followed by HPV31 and HPV18. The frequency of HPV16 sublineages was A1/A2 > D2 > D3 and B1. Moreover, the most frequent mutations, both in samples from this study and in the available sequences from Mexican isolates in the GenBank database were LCR-G7518A, which is involved in carcinogenesis, and E6-T350G (producing L83V), associated with persistence of infection. Otherwise, deep sequencing revealed high conservation of viral lineages and mutations, independently of the stages studied. In conclusion, the high frequency and stability of these molecular markers, as well as the circulating viral lineages, could be related to the incidence of CC associated with HPV16. Hence, they deserve a broader analysis to determine the risk of specific populations for progression of the disease.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31552532     DOI: 10.1007/s00705-019-04407-6

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  3 in total

Review 1.  Epidemiology and Molecular Biology of HPV Variants in Cervical Cancer: The State of the Art in Mexico.

Authors:  J Omar Muñoz-Bello; Adela Carrillo-García; Marcela Lizano
Journal:  Int J Mol Sci       Date:  2022-08-02       Impact factor: 6.208

2.  E6/E7 Variants of Human Papillomavirus 16 Associated with Cervical Carcinoma in Women in Southern Mexico.

Authors:  Ramón Antaño-Arias; Oscar Del Moral-Hernández; Julio Ortiz-Ortiz; Luz Del Carmen Alarcón-Romero; Jorge Adán Navor-Hernández; Marco Antonio Leyva-Vázquez; Marco Antonio Jiménez-López; Jorge Organista-Nava; Berenice Illades-Aguiar
Journal:  Pathogens       Date:  2021-06-20

3.  Analysis of Human Papillomavirus (HPV) 16 Variants Associated with Cervical Infection in Italian Women.

Authors:  Marianna Martinelli; Chiara Villa; Giovanni Sotgiu; Narcisa Muresu; Federica Perdoni; Rosario Musumeci; Romina Combi; Antonio Cossu; Andrea Piana; Clementina Cocuzza
Journal:  Int J Environ Res Public Health       Date:  2020-01-01       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.